Growth Metrics

Braskem (BAK) Current Deferred Revenue (2016 - 2021)

Braskem has reported Current Deferred Revenue over the past 13 years, most recently at $84.6 million for Q3 2021.

  • For Q3 2021, Current Deferred Revenue changed N/A year-over-year to $84.6 million; the TTM value through Sep 2021 reached $84.6 million, changed N/A, while the annual FY2020 figure was $70.8 million, N/A changed from the prior year.
  • Current Deferred Revenue for Q3 2021 was $84.6 million at Braskem, up from $70.8 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $108.9 million in Q4 2017 and troughed at -$12.8 million in Q2 2017.
  • A 5-year average of $48.2 million and a median of $51.7 million in 2018 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: crashed 622.32% in 2017 and later surged 538.8% in 2018.
  • Year by year, Current Deferred Revenue stood at $108.9 million in 2017, then crashed by 63.03% to $40.3 million in 2018, then soared by 85.16% to $74.5 million in 2019, then fell by 4.96% to $70.8 million in 2020, then grew by 19.44% to $84.6 million in 2021.
  • Business Quant data shows Current Deferred Revenue for BAK at $84.6 million in Q3 2021, $70.8 million in Q4 2020, and $74.5 million in Q1 2019.